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Abstract
Background: Skin Sparing Mastectomy (SSM) and immediate breast reconstruction has become
increasingly popular as an effective treatment for patients with breast carcinoma. The aim of this
study was to evaluate the clinical outcome of skin sparing mastectomy in early breast cancer at a
single population-based institution.
Methods: Records of ninety-five consecutive patients with operable breast cancer who had skin-
sparing mastectomy and immediate breast reconstructions between 1995 and 2003 were reviewed.
Patient and tumor characteristic, type of reconstruction, postoperative complications, aesthetic
results and incidence of recurrence were analyzed.
Results: Mean age of the patients was 51.6(range 33–72) years. The AJCC pathologic stages were
0 (n = 51, 53.7%), I (n = 20, 21.1%), and II (n = 2, 2.1%). Twenty of the patients had recurrent disease
(21.1%). The immediate breast reconstructions were performed with autologus tissue including
latissimus dorsi musculocutaneous flap in 63 (66.3%) patients and transverse rectus abdominis
myocutaneous (TRAM) flap in 4 (4.2%) patients. Implants were used in 28 (29.4%) patients. The
average hospital stay was 7.7 days. Flap complication occurred in seven (10.4%) patients resulting
in four (6%) re-operations and there were no delay in accomplishing postoperative adjuvant
therapy. At a median follow-up of 69 months (range 48 to 144), local recurrence was seen in one
patient (1.1%) and systemic recurrence was seen in two patients (2.1%).
Conclusion:  Skin sparing mastectomy and immediate breast reconstruction for early breast
cancer is associated with low morbidity and low rate of local recurrence.
Background
Skin sparing mastectomy (SSM) has become a popular
method for surgical treatment of early stage breast cancer.
This technique was described by Toth and Lappert in 1991
[1]. It consists of a standard mastectomy with resection of
nipple-areola complex and biopsy scar that preserves the
native skin envelope as much as possible. Preservation of
inframammary fold and breast contour facilitates imme-
diate breast reconstruction and provides an ideal color
and texture match of the reconstructed breast and the
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opposite breast. The small scar of SSM could be concealed
in periareolar location, this and the low probability of
nipple-areola complex involvement in early breast cancer
[2-5], has made skin sparing mastectomy with nipple- are-
ola complex preservation as an ideal method regarding
oncological safety and cosmetic results in selected cases
[6].
The risk of skin involvement in T1 and T2 breast carci-
noma is very small [7] and the local recurrence after skin
sparing mastectomy is a reflection of tumor biology rather
than the amount of skin preserved [8-10].
A United King study in 2004 found that 95, 85 and 63 per-
cent of breast surgeons would consider using SSM for
DCIS, T1 and T2 tumors respectively, and 17 percent
would consider the procedure for the treatment of T3
tumors [11]. Many studies have evaluated the local recur-
rence rate and survival rate of SSM and immediate recon-
struction in early breast cancer [12-15]. The incidence of
local recurrence after SSM has been reported as 0 – 7%
[16,17].
The purpose of this study has been to evaluate postopera-
tive morbidity, aesthetic result and safety of SSM in the
management of early breast cancer in our department.
Patients and methods
Ninety-five consecutive patients were reviewed in this
study that were operated on by the skin-spare mastectomy
procedure for their early breast cancer (stage 0, 1, and 2)
and followed by immediate breast reconstruction surgery
at surgical oncology department, Lyon Sud hospital from
April 1995 to April 2003. Chart review was done by one
surgeon (J.Y.B). Only the patients were included in this
study that were followed for at least four years. Follow-up
records gathered from patient's surgical files completed by
their surgeon AJCC staging system [18] was utilized to
classify breast cancers. Indications for operation were cat-
egorized as; primary breast cancer including those with
multicentric tumors or the ones with positive surgical
margins after second lumpectomy (n = 73, 76.8%); recur-
rence following breast conservation surgery and adjuvant
radiotherapy (n = 20, 21.1%); deformity and microcalcifi-
cation after breast conservation surgery (n = 1,), and pro-
phylactic mastectomy (n = 1). All the patients were
discussed regarding different options for their breast
reconstruction surgery before admission.
Skin sparing mastectomy has been classified according to
the type of surgical incision, the amount of skin to be
removed, and the pattern of skin removal. The choice of
incision was chosen according to the size of breast, the
location of the previous biopsy scar, location of the tumor
and to the surgeon preference. Tennis Racquet and periar-
eolar incisions comprised the most common type of the
incisions in our series.
There was Periareolar incisions when a core needle biopsy
was done or a prophylactic mastectomy was planned. A
sentinel node biopsy or an axillary dissection was per-
formed as indicated. Obviously, patients with positive
sentinel node underwent axillary lymph node dissection.
Immediate breast reconstruction techniques were either
autologus tissue transfer muscle flaps (Latissimus dorsi or
Rectus abdominis) or implants. Nipple- areola complex
reconstruction were planned to be done three months
afterward as a separate procedure. A mamoreduction pro-
cedure for the opposite breast was performed in the first
reconstruction operation session.
Adjuvant chemotherapy and radiotherapy were scheduled
when indicated according to the tumor characteristics and
stage of the disease. There were no delay in adjuvant ther-
apies in case of any given breast reconstruction complica-
tions.
Follow up protocols included a 3- or 6-month clinical
review and annual mammography. Patients' median fol-
low up was 69 months (48 to 144). Patients were fol-
lowed until April 2007 in this study. All data were entered
into a dedicated data base (Microsoft Access 2000) and
were analyzed using SPSS 11.5 for windows.
Results
The mean age of patients was 51.6(range 33–72) and
most of them (n = 82, 86.3%) were perimenopause and
postmenopause women who were referred because of
abnormality in screening mammography (microcalcifica-
tion in 76 (80%) patients, nodule in 2 (2%) patients,
other abnormalities in 4 (4%) patients). Only 13 (13.7%)
patients were symptomatic (seven (7.4%) patients with
mass, six (6.3%) patients with discharge and pain).
Positive family history was recorded in 24 (25.3%)
patients (first degree in 18 (18.9%) and second degree in
six (6.3%) patients). The diagnosis of breast cancer was
histologically proven by core cut or needle biopsy in 34
(35.8%) patients or by open biopsy in 61 (64.2%)
patients.
The American Joint Cancer Congress staging were 0(n =
51, 53.7%), I (n = 20, 21.1%), II (n = 2, 2.1%), recurrent
(n = 20, 21.1%)(table 1). There was one case of atypical
lobular hyperplasia with the history of invasive lobular
cancer in opposite breast and one case of deformation and
microcalcification after breast conservative therapy.World Journal of Surgical Oncology 2008, 6:43 http://www.wjso.com/content/6/1/43
Page 3 of 6
(page number not for citation purposes)
In the first half of study (1995–1999), most of the opera-
tions were performed by tennis racquet incision and in
the second half (1999–2003) most of them were per-
formed by periareolar incision. This shift may be due to
more early diagnosis of breast cancer and more use of ster-
eotactic technique in diagnosis of breast carcinoma. All
the margins of mastectomy were negative and the rate of
malignant involvement of nipple-areole complex was
6.3%. Management of axilla includes: sentinel node
biopsy (n = 13, 13.6%), axillary dissection (n = 24,
25.2%) with 11 (11.5%) sampling, 13 (13.6%) conven-
tional dissection, and with no intervention (n = 45,
47.3%). Thirteen patients had history of previous axillary
dissection at the time of breast conservative surgery. Sen-
tinel nodes were positive only in two patients who under-
went subsequent axillary dissection.
For immediate breast reconstruction, we preferred the Lat-
issimus dorsi flap (n = 63, 67%) completely mobilized by
dividing of humeral head. A permanent implant was
inserted under flap in 28 (29%) patients to achieve opti-
mal volume. TRAM flap was used only in 4 (4%) patients
who were obese and required a voluminous flap. Implant
reconstruction was used only when the patient (n = 28,
29%) did not accept any additional incision on the skin.
Surgical complications are recorded in table 2 separately
according to the type of reconstruction. The most com-
mon complication in latissimus dorsi group was seroma
formation in donor site (n = 20, 31.8%) which was man-
aged most often conservatively, open drainage was
needed in 3(15%) patients.
Skin loss in breast envelope flap requiring debridement
and local wound care occurred in 6 (6.3%) patients, four
(66.6%) underwent resection and primary closure
(including three implant removals) and two (33.3%)
healed by secondary closure. Three of them (50%) had
history of breast radiation and nobody was smoker.
Hospital stay was 7.7 days (range 3–19). Eighteen Patients
(18.9%) received adjuvant systemic chemotherapy. Adju-
vant Tamoxifen was given to 31(32.6%) patients. Postop-
erative radiotherapy was given to 3 (3.2%) patients.
Contra-lateral surgeries including reduction mammo-
plasty and mastopexy were done in 18 (18.9%) patients at
the same time of nipple-areole reconstruction. Minority of
patients in this study (n = 11, 11.5%) have needed
implant exchange either because of deformation, dis-
Table 1: Tumor Characteristics
Variable No of patients (%)
Tumor classification
Non invasive 58 (61%)
Comedo 36(37.8%)
non-comedo 22(23.1%)
Invasive 35 (36.8%)
Tumor location
Central 13 (13.6%)
Upper pole 37 (38.9%)
Lower pole 22 (23.1%)
Multicentric 22 (23.1%)
AJCC Staging
05 1  ( 5 3 . 6 % )
12 0  ( 2 1 % )
22  ( 2 . 1 % )
Recurrent 20 (21%)
Grading of the invasive tumors 
I8  ( 8 . 4 % )
II 20 (21%)
III 7 (7.3%)
Table 2: Complications of Skin Sparing Mastectomy and immediate reconstruction according to the type of reconstruction
Complication LD ± P TRAM Prosthesis
Flap related
Partial skin envelope necrosis 3 (4.8%) 0 3 (10.8%)
Partial Flap necrosis 1 (1.6%) 0 0
Periareolar dehiscence 2 (3.2%) 0 0
Contracture and need denervation 1(1.6%) 0 0
Donor site related
Seroma 20(31.8%) 1 (25%) 2(7.1%)
Haematoma 4 (6.3%) 0 0
Superinfection of seroma/haematoma 6 (9.5%) 0 0
Back pain 8 (12.7%) 0 0
Hernia 0 1(25%) 0
Implant related
Displacement 0 0 7 (25%)
Capsular formation 0 0 2 (7.1%)
Total 45(71.4%) 2(50%) 14(50%)World Journal of Surgical Oncology 2008, 6:43 http://www.wjso.com/content/6/1/43
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placement or achieving a more symmetry. Contra-lateral
surgery was needed in 18(18.9%) patients, confirming
better symmetry and decreasing the rate of contra-lateral
surgery after skin sparing mastectomy in comparison with
non-skin sparing mastectomy.
The final aesthetic results were recorded by another sur-
geon (M.E) visiting the patients in clinic at least 6 month
after operation. There were classified as excellent (n = 34,
35.8%), good (n = 54, 56.8%), and fair (n = 7, 7.3%)
according to the Lowery Scaling System [19].
There was one case of regional recurrence in axilla 41
months after skin sparing mastectomy for an in situ carci-
noma. There was no invasive component in the mastec-
tomy specimen of this patient. With more evaluation of
this case distant metastasis were found in the bone and
liver and the patient died in 10 months despite systemic
therapy. There was another case of distant metastasis in
liver 26 months after treatment of an invasive node posi-
tive carcinoma; the patient died in 8 months after diagno-
sis of distant metastasis.
There was one case of second primary invasive cancer of
the opposite breast after two years elapsed of the primary
cancer, which was treated by the same SSM technique.
One smoker patient developed metachronous metastatic
lung cancer five years after treatment for her breast carci-
noma. The patient died during last follow up. Three
patients died because of cardiac events.
Discussion
Rising popularity of skin sparing mastectomy is due to
better understanding of tumor biology and pattern of
recurrence. Data showed that most of patients with local
recurrence would progress to distant metastasis and the
local recurrence could not be considered as an isolated
event resulting from inadequate resections. As with all
other types of mastectomy, SSM leaves some residual
breast tissue behind but it has been proved that the stage
of the primary tumor is the dominant predictor of local
recurrence rather than the amount of tissue remains under
skin flap.
In SSM the endangered breast tissue could be removed
with safe margins while the spared skin could still func-
tion cosmetically. The ideal SSM would have flap thin
enough to remove all breast tissue, but thick enough to
support an adequate blood supply. Torresan et al. [20],
showed a high prevalence of glandular breast tissue and
residual disease in the skin flap thicker than 5 mm. As
with standard mastectomy, obtaining free surgical mar-
gins is essential to skin sparing mastectomy.
The inframammary fold could be left undisturbed and the
thickness of the flap could be the same as those in modi-
fied radical mastectomy. Carlson et al. [21] examined the
inframammary fold tissue in patients undergoing skin-
sparing mastectomy. They found breast tissue in 13 out of
24 specimens, but these tissues comprised only 0.02% of
the total area. Slavin et al. [12] examined 114 skin biop-
sies from 32 patients undergoing skin-sparing mastec-
tomy, and they found none of the biopsies containing
remnant of breast ductal tissue in the dermis. Using SSM,
the reconstructive surgery has changed from a prolonged
procedure to a more rapid operation in which the recon-
structive tissue fills the native skin envelope.
While skin flap necrosis is a recognized complication of
SSM because the skin envelope's blood supply can
become compromised during dissection, this could be
avoided by selecting patients appropriate for the proce-
dure. Nicotine, previous radiotherapy, diabetes and obes-
ity increase the risk of skin envelope ischemia, skin
necrosis and infection. These factors could amplify these
complications additively, so they should be fully
explained to patients before obtaining consent for the
operation [22]. Skin flap necrosis has been estimated to
occur in 11% of SSM as well as non-SSM cases [13]. In this
study we observed very low level of morbidity associated
with this procedure. There were six patients (6.3%) with
skin envelope ischemia in our series, and three of them
(50%) with the history of breast irradiation.
Adjuvant treatment does not seem to be commonly
delayed for a possible skin necrosis following SSM and
immediate breast reconstruction [23,24], although exten-
sive skin envelope necrosis could delay adjuvant treat-
ment in a few individuals affected.
Having done SSM, the overall survival and the local recur-
rence rate has been reported to be similar to the cases
underwent modified radical mastectomy [1,12,14,25]. In
this retrospective study we didn't compare the rate of
recurrence between skin sparing and standard mastec-
tomy because we had selected the best-prognosis patients
with very small tumor for skin-sparing mastectomy and
this selection bias would affect any conclusion.
Although the follow up time in our series has not been
long enough, there were few studies in which the follow
up time of SSM reach as long as 6 years [9,16,25,26]. In
the study reported by Spiegel et al. [26], the follow up time
after SSM is at least six years and the incidence of local
recurrence was 5.5% for invasive carcinoma and 0% for in
situ  carcinoma. In the current study we had only one
recurrence of tumor in the axilla of a patient with ductal
carcinoma in situ 41 months after operation This low rateWorld Journal of Surgical Oncology 2008, 6:43 http://www.wjso.com/content/6/1/43
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of local recurrence is similar to prior published series
(table 3).
We propose that the low rate of local and systemic failure
in our series could be as result of our studied population,
which has been a special subset of very early breast cancer
with inherently good outcome. Ubiruba et al. [27],
reported three cases of local recurrence at the needle
biopsy site in patients treated with SSM whose diagnoses
were obtained through sterotactic needle biopsy. Thirty-
six percent of our patients had history of core needle
biopsy but fortunately without any local recurrence at the
needle biopsy site.
Although the majority of our patients had in situ breast
cancer and small invasive breast carcinoma with extensive
in situ component, more recently SSM has been used to
treat more advanced disease with local recurrence rates
increasing with more advanced stages [28].
Conclusion
In conclusion SSM appears to be oncologically safe for
early breast cancer (stage 0-II), but its use for more
advanced stages require more prospective analysis.
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